Market LIVE
Published markets; coverage varies by country
Product profile · United States

XYOSTED (AUTOINJECTOR)

 ·  Patent Litigation & Settlement History ↓

IngredientTESTOSTERONE ENANTHATE
Application typeNDA
Application209863
Product001
Dosage formSOLUTION
RouteSUBCUTANEOUS
Strength50MG/0.5ML (50MG/0.5ML)
Approval date2018-09-28
Marketing statusPrescription
Status event—
ApplicantANTARES PHARMA INC
Product source

Current GenericRadar decision

Year2035
SelectionDEEP_REVIEW
ReviewFINAL_CHECKING
Anchor typeDS_EQUIVALENT
Anchor date2035-02-19
Patent anchor2035-02-19
Exclusivity anchor2021-09-28
Protection date—
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2035. Anchor type: DS_EQUIVALENT. Patent anchor: 2035-02-19. Exclusivity anchor: 2021-09-28. Anchor date: 2035-02-19. Patent tail: yes. Exclusivity tail: no. Review status: FINAL_CHECKING. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
104785602026-01-24DP ————
———
114464412026-01-24DP ————
———
85625642026-01-24DP ————
———
91802592026-01-24DP ————
———
95331022026-01-24DP ————
———
96299592026-01-24DP ————
———
80213352026-10-04DP ————
———
114977532030-03-19DP ————
———
102791312031-07-31DP ————
———
103576092031-08-21DP ————
———
109058272031-08-21DP ————
———
114464402031-08-21DP ————
———
108210722033-06-04DP/U U-2418———
———
118448042033-06-04U U-2418———
———
108817982034-02-11DP ————
———
111607512034-10-07DP/U U-2418———
———
102386622035-02-19DP/U U-2418———
———
109127822035-02-19DP/U U-2418———
———
118134352035-02-25DP ————
———
126294832035-08-07DP ————
———
111919082035-10-18DP ————
———
97443022035-11-19DP ————
———
99501252036-09-04DP/U U-2418———
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.